Molecular Filters in Medicinal Chemistry

Abstract

Efficient chemical library design for high-throughput virtual screening and drug design requires a pre-screening filter pipeline capable of labeling aggregators, pan-assay interference compounds (PAINS), and rapid elimination of swill (REOS); identifying or excluding covalent binders; flagging moieties with specific bio-evaluation data; and incorporating physicochemical and pharmacokinetic properties early in the design without compromising the diversity of chemical moieties present in the library. This adaptation of the chemical space results in greater enrichment of hit lists, identified compounds with greater potential for further optimization, and efficient use of computational time. A number of medicinal chemistry filters have been implemented in the Konstanz Information Miner (KNIME) software and analyzed their impact on testing representative libraries with chemoinformatic analysis. It was found that the analyzed filters can effectively tailor chemical libraries to a lead-like chemical space, identify protein–protein inhibitor-like compounds, prioritize oral bioavailability, identify drug-like compounds, and effectively label unwanted scaffolds or functional groups. However, one should be cautious in their application and carefully study the chemical space suitable for the target and general medicinal chemistry campaign, and review passed and labeled compounds before taking further in silico steps.

Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology

“…According to Ro5, HBD should be less than 5 (HBD < 5) and HBA less than 10 (HBA < 10). Research in recent years has led to more precise guidelines, as described in detail by Krajl et al [ 26 ].…”

Unveiling Therapeutic Potential: Targeting Fusobacterium nucleatum’s Lipopolysaccharide Biosynthesis for Endodontic Infections—An In Silico Screening Study

“…The advantage of utilizing ADMET filters is to restrict candidates which shows high potential of becoming drugs. Typically, due to the vast quantity of small molecules subjected to virtual screening, only the highest-ranked candidates, constituting the top 10% or less based on their binding energy, were deemed eligible for subsequent evaluation [21,22]. Through rigorous screening, Lomefloxacin and Enoxacin emerged as promising compounds due to their high affinity towards specific target proteins, LpxA and LpxD, respectively.…”

Insight of Natural Compounds Halimane Diterpenoids against &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt;: Virtual Screening, DFT, Drug-Likeness, and Molecular Dynamics Approach

“…Drug-likeness refers to the prediction of whether a specific compound can be developed into a drug. In order to determine drug-likeness, various physiochemical properties of the compound are analyzed using established rules and properties [63].…”